PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+29.47%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.12B
AUM Growth
+$1.12B
(+22%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
6.87%
Top 10 Holdings %
Top 10 Hldgs %
44.03%
Holding
175
New
50
Increased
49
Reduced
22
Closed
29
Top Buys
| 1 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$24.1M |
| 2 |
BLUE
bluebird bio
BLUE
|
$20.6M |
| 3 |
ANI Pharmaceuticals
ANIP
|
$17.6M |
| 4 |
Amicus Therapeutics
FOLD
|
$17.5M |
| 5 |
RLYP
RELYPSA INC COM
RLYP
|
$14.7M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$25.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$22.3M |
| 3 |
Arrowhead Research
ARWR
|
$18.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 5 |
DYAX
DYAX CORPORATION
DYAX
|
$13.8M |
Sector Composition
| 1 | Healthcare | 84.54% |
| 2 | Financials | 0.1% |
| 3 | Energy | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THOR
26
DELISTED
THORATEC CORPORATION
THOR
| $12.7M | 1.07% |
392,465
+244,964
| +166% | +$7.95M |
|
|
XLRN
27
DELISTED
Acceleron Pharma Inc.
XLRN
| $12.4M | 1.04% |
317,636
-127,364
| -29% | -$4.96M |
|
28
Esperion Therapeutics
ESPR
$490M
| $12.2M | 1.03% |
+302,500
| New | +$12.2M |
|
29
Sangamo Therapeutics
SGMO
$161M
| $12.2M | 1.02% |
800,000
| – | – |
|
30
Becton Dickinson
BDX
$54.3B
| $11.1M | 0.93% |
+80,000
| New | +$11.1M |
|
31
Insmed
INSM
$30.3B
| $10.6M | 0.89% |
685,812
+85,812
| +14% | +$1.33M |
|
32
Larimar Therapeutics
LRMR
$337M
| $8.58M | 0.72% |
278,313
+3,313
| +1% | +$102K |
|
|
QTNT
33
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $8.17M | 0.69% |
453,870
+190,026
| +72% | +$3.42M |
|
|
EPZM
34
DELISTED
Epizyme, Inc
EPZM
| $8.16M | 0.68% |
432,619
+148,729
| +52% | +$2.81M |
|
35
MacroGenics
MGNX
$121M
| $7.57M | 0.63% |
215,815
+2,112
| +1% | +$74.1K |
|
|
BDSI
36
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $7.28M | 0.61% |
605,407
+299,407
| +98% | +$3.6M |
|
37
Eledon Pharmaceuticals
ELDN
$155M
| $7.15M | 0.6% |
485,338
+305,338
| +170% | +$4.5M |
|
38
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $7.15M | 0.6% |
+438,000
| New | +$7.15M |
|
|
NVRO
39
DELISTED
NEVRO CORP.
NVRO
| $6.83M | 0.57% |
+176,563
| New | +$6.83M |
|
40
Heron Therapeutics
HRTX
$204M
| $6.7M | 0.56% |
666,042
-219,310
| -25% | -$2.21M |
|
|
AGTC
41
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $6.33M | 0.53% |
301,222
+4,244
| +1% | +$89.2K |
|
|
AFMD
42
DELISTED
Affimed
AFMD
| $6.24M | 0.52% |
1,005,820
+5,831
| +0.6% | +$36.1K |
|
43
Sonida Senior Living
SNDA
$477M
| $6.23M | 0.52% |
+250,000
| New | +$6.23M |
|
|
ASXC
44
DELISTED
Asensus Surgical, Inc.
ASXC
| $6.1M | 0.51% |
2,095,708
+783,767
| +60% | +$2.28M |
|
|
ADYX
45
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $5.95M | 0.5% |
+1,121,951
| New | +$5.95M |
|
|
CEMP
46
DELISTED
Cempra, Inc.
CEMP
| $5.82M | 0.49% |
+247,500
| New | +$5.82M |
|
|
LJPC
47
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $5.33M | 0.45% |
288,955
+38,955
| +16% | +$719K |
|
48
Prothena Corp
PRTA
$452M
| $5.14M | 0.43% |
247,336
-52,664
| -18% | -$1.09M |
|
|
CBPO
49
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $4.98M | 0.42% |
74,023
+71,623
| +2,984% | +$4.82M |
|
|
NDRM
50
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $4.91M | 0.41% |
+350,000
| New | +$4.91M |
|